Rituximab Concept

subject area of

• 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis  Journal Articles
• A Canadian phase II study evaluating the efficacy of rituximab in the management of patients with relapsed/refractory thrombotic thrombocytopenic purpura  Conferences
• A phase‐II sequential case‐series study of all patients presenting to four plasma exchange centres with presumed relapsed/refractory thrombotic thrombocytopenic purpura treated with rituximab  Journal Articles
• A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopenia  Journal Articles
• An atypical case of bilateral posterior scleritis in a patient with chronic lymphocytic leukemia  Journal Articles
• Anti-cytokine targeted therapies for ANCA-associated vasculitis  Journal Articles
• Application of the systematic review and bibliometric network analysis (SeBriNA) methodology contextualizes evidence. Part 2: rituximab for non-Hodgkin's lymphoma  Journal Articles
• Autoimmune haemolytic anaemia associated with epstein barr virus infection as a severe late complication after kidney transplantation and successful treatment with rituximab: case report  Journal Articles
• Autologous Stem Cell Transplantation in Follicular Lymphoma: a Systematic Review and Meta-analysis  Journal Articles
• Autologous Transplantation as Consolidation for Aggressive Non-Hodgkin's Lymphoma  Journal Articles
• Autologous and Allogeneic Stem-Cell Transplantation for Transformed Follicular Lymphoma: A Report of the Canadian Blood and Marrow Transplant Group  Journal Articles
• Autologous transplantation improves survival rates for follicular lymphoma patients who relapse within two years of chemoimmunotherapy: a multi-center retrospective analysis of consecutively treated patients in the real world  Journal Articles
• Bortezomib Added to R-CVP Is Safe and Effective for Previously Untreated Advanced-Stage Follicular Lymphoma: A Phase II Study by the National Cancer Institute of Canada Clinical Trials Group  Journal Articles
• Childhood Immune Thrombocytopenia: A Changing Therapeutic Landscape  Journal Articles
• Conference abstracts of a new oncology drug do not always lead to full publication: Proceed with caution  Journal Articles
• Cost-effectiveness analysis of rituximab with methotrexate, cytarabine and thiotepa for the treatment of patients with primary central nervous system lymphoma  Journal Articles
• Current Options for the Treatment of Idiopathic Thrombocytopenic Purpura  Journal Articles
• Durable remission of both multicentric Castleman's disease and Kaposi's sarcoma with valganciclovir, rituximab and liposomal doxorubicin in an HHV-8-positive, HIV-negative patient  Journal Articles
• Effect of the addition of rituximab to salvage chemotherapy prior to autologous stem cell transplant in aggressive CD20+ lymphoma: a cohort comparison from the NCIC Clinical Trials Group Study LY.12^*  Journal Articles
• Evaluation of Subcutaneous Rituximab Administration on Canadian Systemic Therapy Suites  Journal Articles
• Favorable Outcomes from Allogeneic and Autologous Stem Cell Transplantation for Patients with Transformed Nonfollicular Indolent Lymphoma  Journal Articles
• First-Line Therapy, Autologous Stem-Cell Transplantation, and Post-Transplantation Maintenance in the Management of Newly Diagnosed Mantle Cell Lymphoma  Journal Articles
• Good practice statements (GPS) for the clinical care of patients with thrombotic thrombocytopenic purpura  Journal Articles
• Hepatitis B, Rituximab, Screening, and Prophylaxis: Effectiveness and Cost Effectiveness  Journal Articles
• ISTH guidelines for treatment of thrombotic thrombocytopenic purpura  Journal Articles
• Immunomodulators and immunosuppressants for progressive multiple sclerosis: a network meta-analysis.  Journal Articles
• Immunotherapies in Dermatologic Disorders  Journal Articles
• Immunotherapy with rituximab during peripheral blood stem cell transplantation for non-Hodgkin's lymphoma  Journal Articles
• Improved survival in overweight and obese patients with aggressive B-cell lymphoma treated with rituximab-containing chemotherapy for curative intent  Journal Articles
• In patients with rheumatoid arthritis, bDMARD therapy was not associated with malignant neoplasms  Journal Articles
• Life‐threatening hemolytic anemia due to an autoanti‐Pr cold agglutinin: evidence that glycophorin A antibodies may induce lipid bilayer exposure and cation permeability independent of agglutination  Journal Articles
• Long-term outcomes to fludarabine and rituximab in Waldenström macroglobulinemia  Journal Articles
• Management of antineutrophil cytoplasmic antibody-associated vasculitis: a changing tide  Journal Articles
• Misleading hepatitis B test results due to intravenous immunoglobulin administration: implications for a clinical trial of rituximab in immune thrombocytopenia  Journal Articles
• Mixed Variant Multicentric Castleman Disease Treated With Rituximab: Case Report  Journal Articles
• Monoclonal gammopathy and glomerulopathy associated with chronic lymphocytic leukemia  Journal Articles
• New treatments for idiopathic thrombocytopenic purpura: rethinking old hypotheses  Journal Articles
• Outcomes for transformed follicular lymphoma in the rituximab era: the Royal Marsden experience 2003–2013  Journal Articles
• Outcomes of MYC‐associated lymphomas after R‐CHOP with and without consolidative autologous stem cell transplant: subset analysis of randomized trial intergroup SWOG S9704  Journal Articles
• Outcomes of Patients Treated With RCHOP With a PET-Adapted Approach for Consolidative Radiotherapy: A Retrospective Single-Center Study at the Royal Marsden Hospital  Journal Articles
• Overlapping systemic lupus erythematosus, seropositive erosive rheumatoid arthritis, and ANCA-associated vasculitis: A case report and literature review  Journal Articles
• Phase II multicenter study of oblimersen sodium, a Bcl‐2 antisense oligonucleotide, in combination with rituximab in patients with recurrent B‐cell non‐Hodgkin lymphoma  Journal Articles
• Physician decision making in selection of second‐line treatments in immune thrombocytopenia in children  Journal Articles
• Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis  Journal Articles
• Plasma exchange and glucocorticoids to delay death or end-stage renal disease in anti-neutrophil cytoplasm antibody-associated vasculitis: PEXIVAS non-inferiority factorial RCT  Journal Articles
• Positioning new treatments in the management of immune thrombocytopenia  Journal Articles
• Prevalence and significance of large granular lymphocytes in patients with immune thrombocytopenia  Journal Articles
• Pure red cell aplasia complicating B cell small lymphocytic lymphoma: a case report  Journal Articles
• R-GEM-Lenalidomide versus R-GEM-P as second-line treatment of diffuse large B-cell lymphoma: results of the UK NRCI phase II randomised LEGEND trial  Journal Articles
• Risk infection to spare bleeding? The quandary of splenectomy for immune thrombocytopenia  Journal Articles
• Rituximab Toxicity after Preemptive or Therapeutic Administration for Post-Transplant Lymphoproliferative Disorder  Journal Articles
• Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis  Journal Articles
• Rituximab for Sight-Threatening Lupus-Related Retinal Vasculitis  Journal Articles
• Rituximab in Lymphoma and Chronic Lymphocytic Leukaemia: A Practice Guideline  Journal Articles
• Rituximab in lymphoma: A systematic review and consensus practice guideline from Cancer Care Ontario  Journal Articles
• Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid‐sparing effect  Journal Articles
• Rituximab maintenance for relapsed refractory thrombotic thrombocytopenic purpura  Journal Articles
• Rituximab plus standard of care for treatment of primary immune thrombocytopenia: a systematic review and meta-analysis  Journal Articles
• Rituximab utilization for approved and off‐label nononcology indications and patients’ experiences with the Patient Alert Card  Journal Articles
• Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis  Journal Articles
• Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: an international randomised controlled trial  Journal Articles
• Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial  Journal Articles
• Second‐line treatments in children with immune thrombocytopenia: Effect on platelet count and patient‐centered outcomes  Journal Articles
• Splenectomy for immune thrombocytopenia: down but not out  Journal Articles
• Successful treatment of multiply relapsed lymphoma with rituximab as a single agent  Journal Articles
• Systematic Review: Efficacy and Safety of Rituximab for Adults with Idiopathic Thrombocytopenic Purpura  Journal Articles
• Systematic review of rituximab for autoimmune diseases: a potential alternative to intravenous immune globulin  Journal Articles
• The Completeness of Reporting (CORE) index identifies important deficiencies in observational study conference abstracts  Journal Articles
• The effect of rituximab on anti‐platelet autoantibody levels in patients with immune thrombocytopenia  Journal Articles
• The effect of rituximab on humoral and cell mediated immunity and infection in the treatment of autoimmune diseases  Journal Articles
• The effect of rituximab on vaccine responses in patients with immune thrombocytopenia  Journal Articles
• The role of rituximab in the management of patients with acquired thrombotic thrombocytopenic purpura  Journal Articles
• Thrombopoietin Receptor Agonists and Other Second-Line Therapies for Immune Thrombocytopenia: A Narrative Review With a Focus on Drug Access in Canada  Journal Articles
• Thrombotic thrombocytopenic purpura in pediatric patients.  Journal Articles
• Thrombotic thrombocytopenic purpura: 2008 Update  Journal Articles
• Treatment Strategies in Elderly Patients with Aggressive Histology Lymphoma  Journal Articles
• Treatment and its side effects in ANCA-associated vasculitides – Study based on POLVAS registry data  Journal Articles
• Treatment of Systemic Sclerosis–associated Interstitial Lung Disease: Evidence-based Recommendations. An Official American Thoracic Society Clinical Practice Guideline  Journal Articles
• Tubular Lesions Predict Renal Outcome in Antineutrophil Cytoplasmic Antibody–Associated Glomerulonephritis after Rituximab Therapy  Journal Articles
• Updates in the treatment of granulomatosis with polyangiitis and microscopic polyangiitis: At a crossroad  Journal Articles
• Use and Safety of Immunotherapeutic Management of N-Methyl-d-Aspartate Receptor Antibody Encephalitis  Journal Articles
• Use of anti‐CD20 antibody in the treatment of post‐transplant glomerulonephritis  Journal Articles
• Use of rituximab in paediatric nephrology  Journal Articles